{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:21:15Z","timestamp":1787934075576,"version":"build-2784847793"},"reference-count":132,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Respiratory infections are the most common and most frequent diseases, especially in children and the elderly, characterized by a clear seasonality and with an incidence that usually tends to decrease with increasing age. These infections often resolve spontaneously, usually without the need for antibiotic treatment and\/or with the possible use of symptomatic treatments aimed at reducing overproduction of mucus and decreasing coughing. However, when these infections occur in patients with weakened immune systems and\/or underlying health conditions, their impact can become dramatic and in some cases life threatening. The rapid worldwide spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection has caused concern for everyone, becoming especially important for individuals with underlying lung diseases, such as CF patients, who have always paid close attention to implementing protective strategies to avoid infection. However, adult and pediatric CF patients contract coronavirus infection like everyone else. In addition, although numerous studies were published during the first wave of the pandemic on the risk for patients with cystic fibrosis (CF) to develop severe manifestations when infected with SARS-CoV-2, to date, a high risk has been found only for patients with poorer lung function and post-transplant status. In terms of preventive measures, vaccination remains key. The best protection for these patients is to strengthen preventive measures, such as social distancing and the use of masks. In this review, we aim to summarize and discuss recent advances in understanding the susceptibility of CF individuals to SARS-CoV-2 infection.<\/jats:p>","DOI":"10.3390\/life12122087","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T01:56:06Z","timestamp":1670896566000},"page":"2087","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["SARS-CoV-2 Infection in Patients with Cystic Fibrosis: What We Know So Far"],"prefix":"10.3390","volume":"12","author":[{"given":"Carmelo","family":"Biondo","sequence":"first","affiliation":[{"name":"Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Midiri","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Gerace","sequence":"additional","affiliation":[{"name":"ASP (Azienda Sanitaria Provinciale), 90141 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiana","family":"Zummo","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mancuso","sequence":"additional","affiliation":[{"name":"Department of Human Pathology, University of Messina, 98125 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.7150\/ijbs.45472","article-title":"Zoonotic origins of human coronaviruses","volume":"16","author":"Ye","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"International Committee on Taxonomy of Viruses Executive Committee (2020). The new scope of virus taxonomy: Partitioning the virosphere into 15 hierarchical ranks. Nat. Microbiol., 5, 668\u2013674.","DOI":"10.1038\/s41564-020-0709-x"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/jmv.26048","article-title":"Response to comments on \u201cCross-species Transmission of the Newly Identified Coronavirus 2019-nCoV\u201d and \u201cCodon bias analysis may be insufficient for identifying host(s) of a novel virus\u201d","volume":"92","author":"Ji","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmv.25682","article-title":"Cross-species transmission of the newly identified coronavirus 2019-nCoV","volume":"92","author":"Ji","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jmv.25983","article-title":"Comments on \u201cCross-species transmission of the newly identified coronavirus 2019-nCoV\u201d","volume":"92","author":"Qian","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e26645","DOI":"10.2196\/26645","article-title":"Evolving Epidemiological Characteristics of COVID-19 in Hong Kong From January to August 2020: Retrospective Study","volume":"23","author":"Kwok","year":"2021","journal-title":"J. Med. Internet Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100402","DOI":"10.1016\/j.onehlt.2022.100402","article-title":"Impact of low vaccine coverage on the resurgence of COVID-19 in Central and Eastern Europe","volume":"14","author":"Fan","year":"2022","journal-title":"One Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00148-020-00792-4","article-title":"COVID-19 outbreak, social response, and early economic effects: A global VAR analysis of cross-country interdependencies","volume":"34","author":"Milani","year":"2021","journal-title":"J. Popul. Econ."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.1038\/s41467-021-25915-7","article-title":"Possible future waves of SARS-CoV-2 infection generated by variants of concern with a range of characteristics","volume":"12","author":"Dyson","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41467-020-20688-x","article-title":"Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy","volume":"12","author":"Alteri","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"598547","DOI":"10.3389\/fpubh.2020.598547","article-title":"Ten Epidemiological Parameters of COVID-19: Use of Rapid Literature Review to Inform Predictive Models During the Pandemic","volume":"8","author":"Gallo","year":"2020","journal-title":"Front. Public Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41591-020-0883-7","article-title":"Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy","volume":"26","author":"Giordano","year":"2020","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"o831","DOI":"10.1136\/bmj.o831","article-title":"Covid-19: US tracker overestimated deaths among children","volume":"376","author":"Block","year":"2022","journal-title":"BMJ"},{"key":"ref_19","first-page":"eS4","article-title":"Genetics of cystic fibrosis: Basics","volume":"27","author":"Ferec","year":"2020","journal-title":"Arch. De Pediatr. Organe Off. De La Soc. Fr. De Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.3928\/19382359-20190327-01","article-title":"Review of Cystic Fibrosis","volume":"48","author":"Goetz","year":"2019","journal-title":"Pediatr. Ann."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1556\/EuJMI.2.2012.3.1","article-title":"Spectrum of viral infections in patients with cystic fibrosis","volume":"2","author":"Frickmann","year":"2012","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2013-204000","article-title":"Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis","volume":"69","author":"Flight","year":"2014","journal-title":"Thorax"},{"key":"ref_23","first-page":"e2020035","article-title":"Sars-CoV-2 infection in patients with cystic fibrosis. An overview","volume":"91","author":"Fainardi","year":"2020","journal-title":"Acta Bio-Med. Atenei Parm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jcv.2014.02.005","article-title":"Virus and cystic fibrosis: Rhinoviruses are associated with exacerbations in adult patients","volume":"60","author":"Goffard","year":"2014","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3389\/fimmu.2018.03067","article-title":"Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract","volume":"9","author":"Kiedrowski","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mathew, H.R., Choi, M.Y., Parkins, M.D., and Fritzler, M.J. (2021). Systematic review: Cystic fibrosis in the SARS-CoV-2\/COVID-19 pandemic. BMC Pulm. Med., 21.","DOI":"10.1186\/s12890-021-01528-0"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcf.2020.10.003","article-title":"The global impact of SARS-CoV-2 in 181 people with cystic fibrosis","volume":"19","author":"McClenaghan","year":"2020","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Meyer, V.M.C., Siqueira, M.M., Costa, P., Caetano, B.C., Oliveira Lopes, J.C., Folescu, T.W., and Motta, F.D.C. (2020). Clinical impact of respiratory virus in pulmonary exacerbations of children with Cystic Fibrosis. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0240452"},{"key":"ref_29","first-page":"101226","article-title":"Cystic fibrosis and COVID-19: Care considerations","volume":"31","author":"Mirza","year":"2020","journal-title":"Respir. Med. Case Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41435-020-0103-y","article-title":"COVID-19 meets Cystic Fibrosis: For better or worse?","volume":"21","author":"Peckham","year":"2020","journal-title":"Genes Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2213-2600(20)30177-6","article-title":"Impact of COVID-19 on people with cystic fibrosis","volume":"8","author":"Colombo","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s15010-021-01737-z","article-title":"Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: A study within the Italian Cystic Fibrosis Society","volume":"50","author":"Colombo","year":"2022","journal-title":"Infection"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcf.2020.04.012","article-title":"A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis","volume":"19","author":"Cosgriff","year":"2020","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"102107","DOI":"10.1016\/j.pupt.2021.102107","article-title":"Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes","volume":"72","author":"Pourafkari","year":"2022","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"108693","DOI":"10.1016\/j.vetmic.2020.108693","article-title":"Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses","volume":"244","author":"Decaro","year":"2020","journal-title":"Vet. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/20469047.2020.1781356","article-title":"Human and novel coronavirus infections in children: A review","volume":"41","author":"Rajapakse","year":"2021","journal-title":"Paediatr. Int. Child Health"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-020-02012-8","article-title":"The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection","volume":"99","author":"Santacroce","year":"2021","journal-title":"J. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sharma, H.N., Latimore, C.O.D., and Matthews, Q.L. (2021). Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19. Pathogens, 10.","DOI":"10.3390\/pathogens10091218"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4102\/ojvr.v87i1.1895","article-title":"Zoonotic origins and animal hosts of coronaviruses causing human disease pandemics: A review","volume":"87","author":"Latif","year":"2020","journal-title":"Onderstepoort J. Vet. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2147\/IDR.S357193","article-title":"Clinical Study of Human Coronavirus NL63, OC43, 229E, HKU1 Infentions in Hospitalized Children from 2015 to 2020","volume":"15","author":"Wen","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"877759","DOI":"10.3389\/fped.2022.877759","article-title":"Epidemiology and Clinical Characteristics of Human Coronaviruses-Associated Infections in Children: A Multi-Center Study","volume":"10","author":"Jo","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/ijpvm.IJPVM_429_20","article-title":"Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review","volume":"13","author":"Irani","year":"2022","journal-title":"Int. J. Prev. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"552909","DOI":"10.3389\/fimmu.2020.552909","article-title":"Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses","volume":"11","author":"Abdelrahman","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1097\/01.inf.0000188166.17324.60","article-title":"History and recent advances in coronavirus discovery","volume":"24","author":"Kahn","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_45","unstructured":"Cascella, M., Rajnik, M., Aleem, A., Dulebohn, S.C., and Di Napoli, R. (2022). Features, Evaluation, and Treatment of Coronavirus (COVID-19). StatPearls, StatPearls Publishing."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/jehp.jehp_1328_21","article-title":"Evaluation of coronavirus diseases (COVID-19) in terms of epidemiological and clinical features, comorbidities, diagnostic methods, treatment, and mortality","volume":"11","author":"Cekmen","year":"2022","journal-title":"J. Educ. Health Promot."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41479-021-00092-9","article-title":"Acute respiratory distress syndrome in COVID-19: Possible mechanisms and therapeutic management","volume":"13","author":"Aslan","year":"2021","journal-title":"Pneumonia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.47102\/annals-acadmedsg.202057","article-title":"Rapid Progression to Acute Respiratory Distress Syndrome: Review of Current Understanding of Critical Illness from Coronavirus Disease 2019 (COVID-19) Infection","volume":"49","author":"Goh","year":"2020","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_49","unstructured":"COVID-19 Excess Mortality Collaborators (2022). Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020\u20132021. Lancet, 399, 1513\u20131536."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/d41586-022-00708-0","article-title":"Covid\u2019s True Death Toll: Much Higher Than Official Records","volume":"603","author":"Adam","year":"2022","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/s41467-020-19619-7","article-title":"SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography","volume":"11","author":"Klein","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_52","first-page":"3","article-title":"Properties of Coronavirus and SARS-CoV-2","volume":"42","author":"Malik","year":"2020","journal-title":"Malays. J. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cmrp.2020.04.001","article-title":"An overview of coronaviruses including the SARS-2 coronavirus\u2014Molecular biology, epidemiology and clinical implications","volume":"10","author":"Kaul","year":"2020","journal-title":"Curr. Med. Res. Pract."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1196\/annals.1408.002","article-title":"The molecular biology of SARS coronavirus","volume":"1102","author":"Satija","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1038\/s41467-021-23498-x","article-title":"Author Correction: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"732690","DOI":"10.3389\/fimmu.2021.732690","article-title":"Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19","volume":"12","author":"Kuba","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"847809","DOI":"10.3389\/fcvm.2022.847809","article-title":"Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019","volume":"9","author":"Camargo","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.peptides.2014.07.002","article-title":"Angiotensin 1-7: A peptide for preventing and treating metabolic syndrome","volume":"59","author":"Santos","year":"2014","journal-title":"Peptides"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","article-title":"Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design","volume":"23","author":"Malone","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Romano, M., Ruggiero, A., Squeglia, F., Maga, G., and Berisio, R. (2020). A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells, 9.","DOI":"10.20944\/preprints202004.0510.v1"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: Implications for SARS-CoV-2","volume":"19","author":"Kratzel","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","article-title":"Structural biology of SARS-CoV-2 and implications for therapeutic development","volume":"19","author":"Yang","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Saraste, J., and Prydz, K. (2021). Assembly and Cellular Exit of Coronaviruses: Hijacking an Unconventional Secretory Pathway from the Pre-Golgi Intermediate Compartment via the Golgi Ribbon to the Extracellular Space. Cells, 10.","DOI":"10.3390\/cells10030503"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"eabl4895","DOI":"10.1126\/sciadv.abl4895","article-title":"SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi\/ERGIC and lysosome-mediated egress","volume":"8","author":"Scherer","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"104799","DOI":"10.1016\/j.micpath.2021.104799","article-title":"The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?","volume":"153","author":"Darif","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: Immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41420-021-00428-w","article-title":"SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes","volume":"7","author":"Ferreira","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1017\/S095026882200125X","article-title":"Innate immunity to SARS-CoV-2 infection: A review","volume":"150","author":"Silva","year":"2022","journal-title":"Epidemiol. Infect."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-med-042120-020148","article-title":"Clinical Phenotypes of Cystic Fibrosis Carriers","volume":"73","author":"Polgreen","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1590\/1678-4685-gmb-2018-0148","article-title":"Determining the pathogenicity of CFTR missense variants: Multiple comparisons of in silico predictors and variant annotation databases","volume":"42","author":"Michels","year":"2019","journal-title":"Genet. Mol. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1055\/s-0039-1694964","article-title":"A Novel Pathogenic Variant of the CFTR Gene in a Patient with Cystic Fibrosis Phenotype-c.4096A > T","volume":"9","author":"Arslan","year":"2020","journal-title":"J. Pediatr. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molmed.2011.10.003","article-title":"CFTR: Folding, misfolding and correcting the DeltaF508 conformational defect","volume":"18","author":"Lukacs","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/17476348.2018.1513331","article-title":"Cystic fibrosis respiratory microbiota: Unraveling complexity to inform clinical practice","volume":"12","author":"Caverly","year":"2018","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Scotet, V., L\u2019Hostis, C., and Ferec, C. (2020). The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery. Genes, 11.","DOI":"10.3390\/genes11060589"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3389\/fphys.2018.01585","article-title":"Cystic Fibrosis of the Pancreas: The Role of CFTR Channel in the Regulation of Intracellular Ca2+ Signaling and Mitochondrial Function in the Exocrine Pancreas","volume":"9","author":"Madacsy","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Freswick, P.N., Reid, E.K., and Mascarenhas, M.R. (2022). Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis. Nutrients, 14.","DOI":"10.3390\/nu14071341"},{"key":"ref_80","unstructured":"Adam, M.P., Everman, D.B., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (1993). Cystic Fibrosis and Congenital Absence of the Vas Deferens. GeneReviews\u00ae, University of Washington."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Lukasiak, A., and Zajac, M. (2021). The Distribution and Role of the CFTR Protein in the Intracellular Compartments. Membranes, 11.","DOI":"10.3390\/membranes11110804"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","article-title":"Ion Channel Modulators in Cystic Fibrosis","volume":"154","author":"Gentzsch","year":"2018","journal-title":"Chest"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1801297","DOI":"10.1183\/13993003.01297-2018","article-title":"Pathological mucus and impaired mucus clearance in cystic fibrosis patients result from increased concentration, not altered pH","volume":"52","author":"Hill","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_84","first-page":"S177","article-title":"Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease","volume":"13","author":"Mall","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"601438","DOI":"10.3389\/fphar.2021.601438","article-title":"Cystic Fibrosis Lung Disease in the Aging Population","volume":"12","author":"Kunzi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Averna, M., Melotti, P., and Sorio, C. (2021). Revisiting the Role of Leukocytes in Cystic Fibrosis. Cells, 10.","DOI":"10.3390\/cells10123380"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1164\/rccm.201906-1190PP","article-title":"Targeting Proteases in Cystic Fibrosis Lung Disease. Paradigms, Progress, and Potential","volume":"201","author":"McKelvey","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1159\/000453162","article-title":"CFTR Controls the Activity of NF-kappaB by Enhancing the Degradation of TRADD","volume":"40","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"L509","DOI":"10.1152\/ajplung.00226.2011","article-title":"Does the F508-CFTR mutation induce a proinflammatory response in human airway epithelial cells?","volume":"303","author":"Hampton","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_90","first-page":"59","article-title":"A review of inflammatory mechanism in airway diseases","volume":"68","author":"Aghasafari","year":"2019","journal-title":"Inflamm. Res. Off. J. Eur. Histamine Res. Soc."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcf.2012.07.003","article-title":"Innate immunity in cystic fibrosis lung disease","volume":"11","author":"Hartl","year":"2012","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1165\/rcmb.2008-0408OC","article-title":"TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells","volume":"42","author":"John","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1159\/000446840","article-title":"Current Concepts and Controversies in Innate Immunity of Cystic Fibrosis Lung Disease","volume":"8","author":"Ralhan","year":"2016","journal-title":"J. Innate Immun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"617784","DOI":"10.3389\/fmicb.2021.617784","article-title":"How Bacterial Adaptation to Cystic Fibrosis Environment Shapes Interactions Between Pseudomonas aeruginosa and Staphylococcus aureus","volume":"12","author":"Camus","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"16564","DOI":"10.1038\/s41598-019-52975-z","article-title":"Coexistence with Pseudomonas aeruginosa alters Staphylococcus aureus transcriptome, antibiotic resistance and internalization into epithelial cells","volume":"9","author":"Briaud","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Reece, E., Bettio, P.H.A., and Renwick, J. (2021). Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of Pseudomonas aeruginosa. Antibiotics, 10.","DOI":"10.3390\/antibiotics10070827"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cix203","article-title":"Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study","volume":"64","author":"Somayaji","year":"2017","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_98","first-page":"e9218","article-title":"H1N1 Influenza Virus in Patients With Cystic Fibrosis: A Literature Review Examining Both Disease Entities and Their Association in Light of the 2009 Pandemic","volume":"12","author":"Wiltshire","year":"2020","journal-title":"Cureus"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jcf.2011.06.004","article-title":"Impact of the A (H1N1) pandemic influenza (season 2009\u20132010) on patients with cystic fibrosis","volume":"10","author":"Viviani","year":"2011","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_100","first-page":"357","article-title":"Respiratory syncytial virus (RSV) in infants hospitalized for acute lower respiratory tract disease: Incidence and associated risks","volume":"10","author":"Riccetto","year":"2006","journal-title":"Braz. J. Infect. Dis. Off. Publ. Braz. Soc. Infect. Dis."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Kiedrowski, M.R., Gaston, J.R., Kocak, B.R., Coburn, S.L., Lee, S., Pilewski, J.M., Myerburg, M.M., and Bomberger, J.M. (2018). Staphylococcus aureus Biofilm Growth on Cystic Fibrosis Airway Epithelial Cells Is Enhanced during Respiratory Syncytial Virus Coinfection. mSphere, 3.","DOI":"10.1128\/mSphere.00341-18"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"958658","DOI":"10.3389\/fped.2022.958658","article-title":"Risk factors for severe COVID-19 in people with cystic fibrosis: A systematic review","volume":"10","author":"Terlizzi","year":"2022","journal-title":"Front. Pediatr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/j.jcf.2022.02.012","article-title":"The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York","volume":"21","author":"Simonson","year":"2022","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Colombo, C., Alicandro, G., Dacco, V., Gagliano, V., Morlacchi, L.C., Casciaro, R., Pisi, G., Francalanci, M., Badolato, R., and Bignamini, E. (2021). SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251527"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jcf.2021.03.017","article-title":"Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020","volume":"20","author":"Naehrlich","year":"2021","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"106062","DOI":"10.1016\/j.rmed.2020.106062","article-title":"Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey","volume":"170","year":"2020","journal-title":"Respir. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jcf.2020.08.005","article-title":"SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis","volume":"19","author":"Berardis","year":"2020","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5223\/pghn.2022.25.5.422","article-title":"SARS-CoV-2 Antibodies in Children with Chronic Disease from a Pediatric Gastroenterology Outpatient Clinic","volume":"25","author":"Kaya","year":"2022","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Heiss, R., Tan, L., Schmidt, S., Regensburger, A.P., Ewert, F., Mammadova, D., Buehler, A., Vogel-Claussen, J., Voskrebenzev, A., and Rauh, M. (2022). Pulmonary Dysfunction after Pediatric COVID-19. Radiology, 221250.","DOI":"10.1148\/radiol.221250"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcf.2020.11.021","article-title":"Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study","volume":"20","author":"Bain","year":"2021","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13052-020-00909-1","article-title":"Does cystic fibrosis constitute an advantage in COVID-19 infection?","volume":"46","author":"Bezzerri","year":"2020","journal-title":"Ital. J. Pediatr."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Giron Moreno, R.M., Garcia-Clemente, M., Diab-Caceres, L., Martinez-Vergara, A., Martinez-Garcia, M.A., and Gomez-Punter, R.M. (2021). Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review. Antibiotics, 10.","DOI":"10.3390\/antibiotics10050486"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3389\/fphar.2020.01096","article-title":"Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies","volume":"11","author":"Mitri","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thoraxjnl-2021-217782","article-title":"Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: A randomised, controlled clinical trial","volume":"77","author":"Nichols","year":"2022","journal-title":"Thorax"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcf.2005.05.010","article-title":"Anti-inflammatory therapy in cystic fibrosis","volume":"4","author":"Dinwiddie","year":"2005","journal-title":"J. Cyst. Fibros. Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s42399-020-00610-8","article-title":"Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): A Review","volume":"2","author":"Ahmed","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1080\/17476348.2020.1804365","article-title":"Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: A systematic review and meta-analysis","volume":"14","author":"Hasan","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/14787210.2020.1813024","article-title":"Azithromycin in the treatment of COVID-19: A review","volume":"19","author":"Ferrandez","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2040206620961712","DOI":"10.1177\/2040206620961712","article-title":"Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond","volume":"28","author":"Poddighe","year":"2020","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e2163","DOI":"10.1002\/rmv.2163","article-title":"Azithromycin in viral infections","volume":"31","author":"Oliver","year":"2021","journal-title":"Rev. Med. Virol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"106053","DOI":"10.1016\/j.ijantimicag.2020.106053","article-title":"Macrolides and viral infections: Focus on azithromycin in COVID-19 pathology","volume":"56","author":"Pani","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"583862","DOI":"10.3389\/fphys.2020.583862","article-title":"A Scientific Rationale for Using Cystic Fibrosis Transmembrane Conductance Regulator Therapeutics in COVID-19 Patients","volume":"11","author":"Lidington","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Regard, L., Martin, C., Burnet, E., Da Silva, J., and Burgel, P.R. (2022). CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France. Cells, 11.","DOI":"10.3390\/cells11111769"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Lotti, V., Merigo, F., Lagni, A., Di Clemente, A., Ligozzi, M., Bernardi, P., Rossini, G., Concia, E., Plebani, R., and Romano, M. (2022). CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells. Cells, 11.","DOI":"10.3390\/cells11081347"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e20210583","DOI":"10.1084\/jem.20210583","article-title":"Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics","volume":"218","author":"Cheemarla","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Merigo, F., Lotti, V., Bernardi, P., Conti, A., Clemente, A.D., Ligozzi, M., Lagni, A., Sorio, C., Sbarbati, A., and Gibellini, D. (2022). Ultrastructural Characterization of Human Bronchial Epithelial Cells during SARS-CoV-2 Infection: Morphological Comparison of Wild-Type and CFTR-Modified Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179724"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Flume, P.A., Saiman, L., and Marshall, B. (2021). The Impact of COVID-19 in Cystic Fibrosis. Arch. De Bronconeumol.","DOI":"10.1016\/j.arbres.2021.12.003"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Thee, S., Busack, L.M., Mall, M.A., and Stahl, M. (2022). Impact of lockdown during the COVID-19 pandemic on health status in patients with cystic fibrosis: A mono-centre observational study. ERJ Open Res., 8.","DOI":"10.1183\/23120541.00588-2021"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"e2021118","DOI":"10.1590\/1984-0462\/2022\/40\/2021118in","article-title":"Telemedicine of patients with cystic fibrosis during the COVID-19 pandemic","volume":"40","author":"Costa","year":"2022","journal-title":"Rev. Paul. De Pediatr. Orgao Of. Da Soc. De Pediatr. De Sao Paulo"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"ooac005","DOI":"10.1093\/jamiaopen\/ooac005","article-title":"Cystic fibrosis telemedicine in the era of COVID-19","volume":"5","author":"Rad","year":"2022","journal-title":"JAMIA Open"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e001529","DOI":"10.1136\/bmjoq-2021-001529","article-title":"Home spirometry utilisation in telemedicine clinic for cystic fibrosis care during COVID-19 pandemic: A quality improvement process","volume":"10","author":"Compton","year":"2021","journal-title":"BMJ Open Qual."},{"key":"ref_132","first-page":"23","article-title":"Telemedicine and cystic fibrosis: Do we still need face-to-face clinics?","volume":"42","author":"Dixon","year":"2022","journal-title":"Paediatr. Respir. Rev."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/12\/2087\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:40:10Z","timestamp":1760146810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/12\/12\/2087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":132,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["life12122087"],"URL":"https:\/\/doi.org\/10.3390\/life12122087","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]}}}